Whole Transcriptomics Sequencing Market

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
Whole Transcriptomics Sequencing Market aims to provide a comprehensive presentation of the global market for Whole Transcriptomics Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Transcriptomics Sequencing. Whole Transcriptomics Sequencing Market contains market size and forecasts of Whole Transcriptomics Sequencing in global, including the following market information:
Global Whole Transcriptomics Sequencing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Whole Transcriptomics Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Whole Transcriptomics Sequencing include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Whole Transcriptomics Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Whole Transcriptomics Sequencing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Whole Transcriptomics Sequencing Market Segment Percentages, by Type, 2022 (%)
PCR
Microarray
Sequencing
Global Whole Transcriptomics Sequencing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Whole Transcriptomics Sequencing Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Global Whole Transcriptomics Sequencing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Whole Transcriptomics Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Whole Transcriptomics Sequencing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Whole Transcriptomics Sequencing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Whole Transcriptomics Sequencing, market overview.
Chapter 2: Global Whole Transcriptomics Sequencing market size in revenue.
Chapter 3: Detailed analysis of Whole Transcriptomics Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Whole Transcriptomics Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.